Analysis on clinical benefits induced by adjuvant chemotherapy for elderly patients with high risk stage Ⅱ and stage Ⅲ colorectal cancer after radical resection surgery

YU Chun-bo,XU Qing,CHEN Jin-xian,ZHANG Jing

DOI: https://doi.org/10.3969/cma.j.issn.1674-0785.2013.14.036

2013-01-01

Abstract:Objective To explore the clinical benefits of adjuvant chemotherapy in elderly patients with high risk stage Ⅱ and stage Ⅲ colorectal cancer after radical resection surgery. Methods This study retrospectively analyzed the clinical data from 1166 patients≥70 years-old who received radical resection surgery. They were divided into chemotherapy group(n=541)and non chemotherapy group(n=625). the difference in disease-free survival(DFS), tumor relapse and metastasis rate between two groups was analyzed by Kaplan-Meier method and COX proportional hazard models. Results The 3 years relapse and metastasis rates of two groups were 24.4% and 40.2%, P<0.05, such as the 5 years were 43.3% and 54.1%, P<0.05, there were significant differences between the two groups.The 3 years disease-free survival rates of two groups were 74.9% and 57.7%, P<0.05; such as the 5 years were 56.1% and 43.1%, P<0.05, the differences were statistically significant.The median disease-free survival time of two groups was 37 months and 31 months, P<0.05. The difference was statistically significant. Conclusion Adjuvant chemotherapy reduce the relapse and metastasis rates and improve the DFS in elderly patients with high risk stage Ⅱ and stage Ⅲ colorectal cancer after radical resection surgery.